Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Zynerba Pharmaceuticals, Inc.

Clinical trials sponsored by Zynerba Pharmaceuticals, Inc., explained in plain language.

Now part of Harmony Biosciences Holdings, Inc. HRMY NASDAQ

Pharmaceutical company developing cannabinoid-based therapies for neurological disorders.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 1

CBD gel shows promise for fragile x behaviors in major trial

Symptom relief Completed

This study tested a cannabidiol (CBD) gel, called ZYN002, applied to the skin in 215 children, teens, and young adults with Fragile X syndrome. The goal was to see if it could improve behavioral symptoms like irritability and social withdrawal. Participants received either the CB…

Phase: PHASE3 • Sponsor: Zynerba Pharmaceuticals, Inc. • Aim: Symptom relief

Last updated Jun 27, 2026 08:04 UTC